Lymphangioleiomyomatosis Clinical Trials in New York, New York
2 recruitingNew York, New York
Showing 1–2 of 2 trials
Recruiting
Phase 1
Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
LymphangioleiomyomatosisLymphangioleiomyomatosis (LAM)
Columbia University20 enrolled2 locationsNCT06889168
Recruiting
TSC Biosample Repository and Natural History Database
LymphangioleiomyomatosisTuberous Sclerosis
National Tuberous Sclerosis Association5,000 enrolled24 locationsNCT05676099